We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Impact of the COVID-19 crisis on imaging in oncological trials.
- Authors
Deroose, Christophe M.; Lecouvet, Frédéric E.; Collette, Laurence; Oprea-Lager, Daniela E.; Kunz, Wolfgang G.; Bidaut, Luc; Verhoeff, Joost J. C.; Caramella, Caroline; Lopci, Egesta; Tombal, Bertrand; de Geus-Oei, Lioe-Fee; Fournier, Laure; Smits, Marion; deSouza, Nandita M.
- Abstract
Many imaging-based clinical trials, however, merely incorporate research imaging as an additional component to routine imaging or utilise images acquired for clinical care. Contacting patients prior to the imaging visit, enquiring about possible symptoms, should reassure them that safety procedures are enforced and that imaging examinations can be re-scheduled where needed. Moreover, as imaging studies may potentially reveal incidental findings suggestive of pandemic-related (COVID-19) infection, information from structured and timely review of imaging findings communicated early to patients within trials would further incentivise them to attend imaging sessions. Organisational issues - institution and department policies Trial-related imaging, currently delayed due to any "lockdown" strategy adopted in most countries and pandemic-related priorities, is delayed further by post-pandemic imaging capacity limits.
- Subjects
COVID-19 pandemic; PANDEMICS; COVID-19
- Publication
European Journal of Nuclear Medicine & Molecular Imaging, 2020, Vol 47, Issue 9, p2054
- ISSN
1619-7070
- Publication type
Editorial
- DOI
10.1007/s00259-020-04910-y